FilingReader Intelligence
Shanghai RAAS proposes switch from KPMG to EY
July 21, 2025 at 12:35 PM UTC•By FilingReader AI
Shanghai RAAS Blood Products has proposed appointing Ernst & Young Hua Ming as its new accounting firm for 2025, replacing KPMG Huazhen. The change requires shareholder approval at an extraordinary general meeting on July 31, 2025.
The company has also amended its articles of association to include provisions for share repurchases, allowing it to acquire its own shares for purposes including maintaining company value and shareholder equity.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Announcement on the resolutions of the seventh meeting of the sixth supervisory boardJuly 15, 2025 at 03:54 PM UTC
Announcement regarding the resolutions of the twelfth (extraordinary) meeting of the sixth board of directorsJuly 15, 2025 at 03:54 PM UTC
Notice of convening the second extraordinary general meeting of shareholders in 2025July 15, 2025 at 03:54 PM UTC
Announcement on the proposed appointment of the accounting firm for the 2025 fiscal yearJuly 15, 2025 at 03:54 PM UTC
News Alerts
Get instant email alerts when Shanghai RAAS Blood Products publishes news
Free account required • Unsubscribe anytime